Colostrum

Last updated
Bovine colostrum and spray-dried colostrum powder Bovine colostrum and spray-dried colostrum powder.jpg
Bovine colostrum and spray-dried colostrum powder
On the left is milk expressed on day 4 of lactation, and on the right is breastmilk expressed on day 8. Colostrum gives the milk a yellow hue. Colostrum vs breastmilk.jpg
On the left is milk expressed on day 4 of lactation, and on the right is breastmilk expressed on day 8. Colostrum gives the milk a yellow hue.

Colostrum (known colloquially as beestings, [1] bisnings [2] or first milk) is the first form of milk produced by the mammary glands of mammals (including humans) immediately following delivery of the newborn. [3] Most species will begin to generate colostrum just prior to giving birth. Colostrum has especially high amounts of bioactive compounds compared to mature milk to give the newborn the best possible start to life. Specifically, colostrum contains antibodies to protect the newborn against disease and infection, and immune and growth factors and other bioactives that help to activate a newborn’s immune system, jumpstart gut function, and seed a healthy gut microbiome in the first few days of life. The bioactives found in colostrum are essential for a newborn’s health, growth and vitality.

Contents

At birth, the surroundings of the newborn mammal change from the relatively sterile environment in the mother’s uterus, with a constant nutrient supply via the placenta, to the microbe rich environment outside with irregular oral intake of complex milk nutrients through the gastrointestinal tract. [4] This transition puts high demands on the gastrointestinal tract of the neonate, as the gut plays an important part in both the digestive system and the immune system. [5] Colostrum has evolved to care for highly sensitive mammalian neonates, and contributes significantly to initial immunological defense as well as to the growth, development, and maturation of the neonate’s gastrointestinal tract by providing key nutrients and bioactive factors. [6] [7]

Colostrum also has a mild laxative effect, encouraging the passing of the baby's first stool, which is called meconium. This clears excess bilirubin, a waste-product of dead red blood cells, which is produced in large quantities at birth due to blood volume reduction from the infant's body and helps prevent jaundice.

Bioactive components in colostrum

Newborns have very immature and small digestive systems, and colostrum delivers its bioactives in a very concentrated low-volume form. Colostrum is known to contain immune cells (as lymphocytes) [8] [9] and many antibodies such as IgA, IgG, and IgM. These are some of the components of the adaptive immune system. Other immune components of colostrum include the major components of the innate immune system, such as lactoferrin, [10] lysozyme, [11] lactoperoxidase, [12] complement, [13] and proline-rich polypeptides (PRP). [14] A number of cytokines (small messenger peptides that control the functioning of the immune system) are found in colostrum as well, [15] including interleukins, [15] tumor necrosis factor, [16] chemokines, [17] and others.

Colostrum also contains a number of growth factors, such as insulin-like growth factors I (IGF-1), [18] and II, [19] transforming growth factors alpha, [20] beta 1 and beta 2, [21] [22] fibroblast growth factors, [23] epidermal growth factor, [24] granulocyte-macrophage-stimulating growth factor, [25] platelet-derived growth factor, [25] vascular endothelial growth factor, [26] and colony-stimulating factor-1. [27]

Human consumption of bovine colostrum

While it’s long been understood that the colostrum a mother produces is vital to a newborn’s health in the first few days of life, research has shown that bovine (cow) colostrum and its components can continue to support important biological activities when given to more mature children and adults, so that the benefits of colostrum can extend well beyond the neonatal period of development.

Bovine colostrum and human colostrum are highly similar in their makeup, both containing many of the same antibodies, immune and growth factors, and other nutrients. [28] Because they share so many of the same components, the way they work in the body is also highly similar. The benefit of bovine colostrum for human health has been studied in many areas including:

Colostrum use in animal husbandry

Colostrum is crucial for newborn farm animals. They receive no passive transfer of immunity via the placenta before birth, so any antibodies that they need have to be ingested (unless supplied by injection or other artificial means). The ingested antibodies are absorbed from the intestine of the neonate. [45] [46] [47] [48] [49] The newborn animal must receive colostrum within 6 hours of being born for maximal absorption of colostral antibodies to occur. Recent studies indicate that colostrum should be fed to bovines within the first thirty minutes to maximize IgG absorption rates. [50]

The role of colostrum for new born animals is in the provision of nutrition and also essential protection again infection while the immune and digestive systems are developing and maturing. Bovine colostrum provides macro and micro nutrients, as well as growth factors, cytokines, nucleosides, oligosaccharides, natural antimicrobials, antioxidants and a range of immunoglobulins such as IgG, IgA, IgD, IgM and IgE. It is well established that minimal levels of IgG are essential to prevent failure of passive transfer. The iron binding glycoproteins lactoferrin and transferrin in bovine colostrum assist in attacking pathogens by impacting their cell membrane and making them more susceptible to the immune systems attack by neutrophils. Cytokines present in bovine colostrum enhance B and T cell maturation and increase endogenous antibody production. They also play a major role in regulation of epithelial cell growth and development, proliferation, restitution. Transfer factors enhance the activity of T cells. Other growth and immune factors such as IGF-1, IGF-2, FGF, EGF, TGF, PDGF, etc.

Bovine colostrum’s components benefit the immune and digestive health of animals of all ages and species. Bovine colostrum’s vast array of bioactive components collectively increase resistance to infection and disease caused by a wide range of pathogens including bacteria and viruses. The quality of the colostrum is essential in providing the essential benefits. Both contaminated early bovine colostrum at the farm level or late transition milk or milk are poor sources of the important colostral components necessary to maintain life and achieve and maintain healthy animal maturation and homoeostasis. Bovine colostrum also is beneficial in repairing or healing intestinal damage as well as increasing the absorption of nutrients from the GI tract. These properties and benefits are consistent among human and animal species.

The transition from fetal to neonatal and shift from maternal to environmental reliance requires an abrupt immunological change. In calves, for example, colostrum provides a significant benefit in neonatal intestine development. This includes villus area, circumference, height and height/crypt ratio. Colostrum is critically important to calves and foals in order to prevent failure of passive transfer and death. Calves, foals and piglets with low IgG levels have an increased risk of morbidity and mortality. Bovine colostrum can be used to reduce the duration and severity of infections so it can be a useful tool to include in the reduction of antibiotic use. Finally, another important and valuable benefit of colostrum is in the reduction in scours and increase in average daily weight gain all of which have a significant farmer and ultimately consumer benefit.  

Colostrum use in companion animals

Much like in humans and production animals, companion animal survival in the newborn stage of life is largely dependent upon colostrum. Companion animal immune systems require several weeks to several months in order to fully develop. Maternal antibodies provide benefit for a relatively short period of time so a gap exists with immune sufficiency where an animal is at risk of infection. Like humans, companion animal immune response changes with age where early life and later in life have similarities. That is, an immune bias whereby the animal has less of an ability to fend off infections and greater prevalence of allergy at both ends of the age spectrum. Stress also affects a companion animal’s immune system including changes in environment, diet, etc. Maintaining gut microbial balance is key to maintaining a healthy immune system as well as mucosal integrity, similar to humans. Bovine colostrum has been demonstrated to benefit companion animal immunity and digestive health.

Bovine colostrum plays a role in increasing Ig levels, increasing lymphocyte proliferation stimulating activity and increasing phagocytosis activity. These are supported by other components of colostrum which further enhance the activity of the immune response. The iron binding glycoproteins lactoferrin and transferrin in bovine colostrum assist in attacking pathogens by impacting their cell membrane and making them more susceptible to the immune systems attack by neutrophils. Cytokines present in bovine colostrum enhance B and T cell maturation and increase endogenous antibody production. They also play a major role in regulation of epithelial cell growth and development, proliferation, restitution. Transfer factors enhance the activity of T cells. Other growth and immune factors such as IGF-1, IGF-2, FGF, EGF, TGF, PDGF, etc. Colostrum contains glycomacropeptides which help to regulate appetite .

Bovine colostrum has been shown to enhance immune response in animal models including canine, feline and equine animals including maintaining a higher level of vaccine antibody response over time and for a longer period than the vaccine alone. Animals fed colostrum had a significantly higher local immune status resulting in higher IgA through GALT stimulation. Colostrum also plays a key role in reduction or prevention of diarrhea and reduction in respiratory illness.

Bovine colostrum history of study and potential future applications

Solidified colostrum in a sweet stall, Salem, Tamil Nadu. Colostrum cakes.JPG
Solidified colostrum in a sweet stall, Salem, Tamil Nadu.
Molozyvo--a traditional dish of Ukrainian cuisine. It is a sweet cheese made of cow colostrum. Molozyvo.jpg
Molozyvo—a traditional dish of Ukrainian cuisine. It is a sweet cheese made of cow colostrum.

Dairy cattle are naturally exposed to pathogens and produce immunoglobulins against them. These antibodies are present in the cow’s bloodstream and in the colostrum. These immunoglobulins are specific to many human pathogens, including Escherichia coli, Cryptosporidium parvum, Shigella flexneri, Salmonella species, Staphylococcus species, [51] and rotavirus (which causes diarrhea in infants). Before the development of antibiotics, colostrum was the main source of immunoglobulins used to fight bacteria. In fact, when Albert Sabin made his first oral vaccine against polio, the immunoglobulin he used came from bovine colostrum. [52] When antibiotics began to appear, interest in colostrum waned, but, now that antibiotic-resistant strains of pathogens have developed, interest is once again returning to natural alternatives to antibiotics, namely, colostrum. [53]

Although bovine colostrum has been consumed by humans for centuries, [54] only in recent decades have we seen an increase in randomized clinical trials to support assertions of health benefits. It is probable that little absorption of intact growth factors and antibodies into the bloodstream occurs, due to digestion in the gastrointestinal tract. However, the presence of casein and other buffering proteins does allow growth factors and other bioactive molecules to pass into the lumen of the small intestine intact, where they can stimulate repair and inhibit microbes, working via local effects. [55] This provides a probable mechanism explaining the positive results of colostrum on adult gut health in several recent well controlled published studies. [56] [57] [58] [59] Evidence for the beneficial effect of colostrum on extra-gastrointestinal problems is less well developed, due in part to the limited number of randomised double-blind studies published, although a variety of possible uses have been suggested. [60] [61] [62]

The gut plays several important roles including acting as the main pathway for fluid, electrolyte and nutrient absorption while also acting as a barrier to toxic agents present in the gut lumen including acid, digestive enzymes and gut bacteria. It is also a major immunological defence mechanism, detecting natural commensals and triggering immune response when toxic microbes are present. Failure of homeostasis due to trauma, drugs and infectious microbes not only damages the gut but can lead to influx of damaging agents into the bloodstream. These mechanisms have relevance for multiple conditions affecting all areas of the world and socioeconomic groups such as ulcers, inflammation, and infectious diarrhea. [63] There is currently much interest in the potential value of colostrum for the prevention and treatment of these conditions as it is derived from natural sources and can influence damaging factors through multiple pathways including nutritional support, immunological intervention (through its immunoglobulin and other anti-microbial factors) and growth/healing factor constituents. [64] As pointed out by Kelly, inconsistency between results in some published studies may be due in part to variation in dose given and to the timing of the colostrum collection being tested (first milking versus pooled colostrum collected up to day 5 following calving). [65]

Some athletes have used colostrum in an attempt to improve their performance, [66] decrease recovery time, [67] and prevent sickness during peak performance levels. [68] [69] Supplementation with bovine colostrum, 20 grams per day (g/d), in combination with exercise training for 8 wk may increase bone-free lean body mass in active men and women. [66] [70]

Low IGF-1 levels may be associated with dementia in the very elderly, although causation has not been established. [71] Malnutrition can cause low levels of IGF-1, [72] as can obesity. [73] Supplementation with colostrum, which is rich in IGF-1, can be a useful part of a weight reduction program.[ citation needed ] Although IGF-1 is not absorbed intact by the body, some studies suggest it stimulates the production of IGF-1 when taken as a supplement [74] whereas others do not [75]

Colostrum also has antioxidant components, such as lactoferrin [76] and hemopexin, which binds free heme in the body. [77]

The Isle of Man had a local delicacy called "Groosniuys", a pudding made with colostrum. [78] In Finland, a baked cheese called Leipäjuusto is traditionally made with either cow colostrum or reindeer milk.

A sweet cheese-like delicacy called 'Junnu' is made with colostrum in the south Indian states of Andhra Pradesh and Telangana. It is made with both cow and buffalo milk; in both cases it is the milk produced on the second day after giving birth which is considered best for making this pudding-like delicacy. Colostrum is in very high demand in these states, resulting in product adulteration.

Hyperimmune colostrum

Hyperimmune colostrum is natural bovine colostrum collected from a population of cows immunized repeatedly with a specific pathogen. The colostrum is collected within 24 hours of the cow giving birth. Antibodies towards the specific pathogens or antigens that were used in the immunization are present in higher levels than in the population before treatment. Although some papers have been published stating that specific human pathogens were just as high as in hyperimmune colostrum, and natural colostrum nearly always had higher antibody titers than did the hyperimmune version. [51] Clinical trials [79] have shown that if the immunization is by surface antigens of the bacteria, the Bovine Colostrum Powder [80] can be used to make tablets capable of binding to the bacteria so that they are excreted in stools. This prevents the successful colonization of the gut, which would otherwise lead to bacteria releasing enterotoxigenic materials.

Proline-rich polypeptides

These small immune signaling peptides (PRPs) were independently discovered in colostrum and other sources, such as blood plasma, in the United States, [81] Czechoslovakia and Poland. [82] Hence they appear under various names in the literature, including Colostrinin, CLN, transfer factor and PRP. They function as signal transducing molecules that have the unique effect of modulating the immune system, turning it up when the body comes under attack from pathogens or other disease agents, and damping it when the danger is eliminated or neutralized. [83] At first thought to actually transfer immunity from one immune system to another, it now appears that PRPs simply stimulate cell-mediated immunity. [84]

Related Research Articles

Antibody Immune system protein

An antibody (Ab), also known as an immunoglobulin (Ig), is a large, Y-shaped protein used by the immune system to identify and neutralize foreign objects such as pathogenic bacteria and viruses. The antibody recognizes a unique molecule of the pathogen, called an antigen. Each tip of the "Y" of an antibody contains a paratope that is specific for one particular epitope on an antigen, allowing these two structures to bind together with precision. Using this binding mechanism, an antibody can tag a microbe or an infected cell for attack by other parts of the immune system, or can neutralize it directly.

Immunology Branch of medicine studying the immune system

Immunology is a branch of biology that covers the study of immune systems in all organisms. Immunology charts, measures, and contextualizes the physiological functioning of the immune system in states of both health and diseases; malfunctions of the immune system in immunological disorders ; and the physical, chemical, and physiological characteristics of the components of the immune system in vitro, in situ, and in vivo. Immunology has applications in numerous disciplines of medicine, particularly in the fields of organ transplantation, oncology, rheumatology, virology, bacteriology, parasitology, psychiatry, and dermatology.

Kitten Juvenile cat

A kitten is a juvenile cat. After being born, kittens display primary altriciality and are totally dependent on their mother for survival. They do not normally open their eyes until after seven to ten days. After about two weeks, kittens quickly develop and begin to explore the world outside the nest. After a further three to four weeks, they begin to eat solid food and grow adult teeth. Domestic kittens are highly social animals and usually enjoy human companionship.

Rh disease is a type of hemolytic disease of the fetus and newborn (HDFN). HDFN due to anti-D antibodies is the proper and currently used name for this disease as the Rh blood group system actually has more than 50 antigens and not only D-antigen. The term "Rh Disease" is not the current terminology but it is commonly used to refer to HDFN due to anti-D antibodies, and prior to the discovery of anti-Rho(D) immune globulin, it was the most common type of HDFN. The disease ranges from mild to severe, and occurs in the second or subsequent pregnancies of Rh-D negative women when the biologic father is Rh-D positive.

Immunoglobulin G (IgG) is a type of antibody. Representing approximately 75% of serum antibodies in humans, IgG is the most common type of antibody found in blood circulation. IgG molecules are created and released by plasma B cells. Each IgG has two antigen binding sites.

Immunoglobulin A Antibody that plays a crucial role in the immune function of mucous membranes

Immunoglobulin A is an antibody that plays a crucial role in the immune function of mucous membranes. The amount of IgA produced in association with mucosal membranes is greater than all other types of antibody combined. In absolute terms, between three and five grams are secreted into the intestinal lumen each day. This represents up to 15% of total immunoglobulins produced throughout the body.

Immunoglobulin M One of several isotypes of antibody

Immunoglobulin M (IgM) is one of several isotypes of antibody that are produced by vertebrates. IgM is the largest antibody, and it is the first antibody to appear in the response to initial exposure to an antigen. In the case of humans and other mammals that have been studied, the spleen, where plasmablasts responsible for antibody production reside, is the major site of specific IgM production.

Bovine somatotropin Peptide hormone produced by cows pituitary glands

Bovine somatotropin or bovine somatotrophin, or bovine growth hormone (BGH), is a peptide hormone produced by cows' pituitary glands.

Breast milk

Breast milk or mother's milk is milk produced by mammary glands located in the breast of a human female to feed a young child. Breast milk is the primary source of nutrition for newborns before they are able to eat and digest other foods; older infants and toddlers may continue to be breastfed, but solid foods should be introduced in combination starting from six months of age.

Hemolytic disease of the newborn Fetal and neonatal alloimmune blood condition

Hemolytic disease of the newborn, also known as hemolytic disease of the fetus and newborn, HDN, HDFN, or erythroblastosis foetalis, is an alloimmune condition that develops in a fetus at or around birth, when the IgG molecules produced by the mother pass through the placenta. Among these antibodies are some which attack antigens on the red blood cells in the fetal circulation, breaking down and destroying the cells. The fetus can develop reticulocytosis and anemia. The intensity of this fetal disease ranges from mild to very severe, and fetal death from heart failure can occur. When the disease is moderate or severe, many erythroblasts are present in the fetal blood, earning these forms of the disease the name erythroblastosis fetalis.

Transfer factor

Transfer factors are essentially small immune messenger molecules that are produced by all higher organisms. Transfer factors were originally described as immune molecules that are derived from blood or spleen cells that cause antigen-specific cell-mediated immunity, primarily delayed hypersensitivity and the production of lymphokines, as well as binding to the antigens themselves. They have a molecular weight of approximately 5000 Daltons and are composed entirely of amino acids. Transfer factors were discovered by Henry Sherwood Lawrence in 1954.

In ABO hemolytic disease of the newborn maternal IgG antibodies with specificity for the ABO blood group system pass through the placenta to the fetal circulation where they can cause hemolysis of fetal red blood cells which can lead to fetal anemia and HDN. In contrast to Rh disease, about half of the cases of ABO HDN occur in a firstborn baby and ABO HDN does not become more severe after further pregnancies.

Microfold cells are found in the gut-associated lymphoid tissue (GALT) of the Peyer's patches in the small intestine, and in the mucosa-associated lymphoid tissue (MALT) of other parts of the gastrointestinal tract. These cells are known to initiate mucosal immunity responses on the apical membrane of the M cells and allow for transport of microbes and particles across the epithelial cell layer from the gut lumen to the lamina propria where interactions with immune cells can take place.

Passive immunity is the transfer of active humoral immunity of ready-made antibodies. Passive immunity can occur naturally, when maternal antibodies are transferred to the fetus through the placenta, and it can also be induced artificially, when high levels of antibodies specific to a pathogen or toxin are transferred to non-immune persons through blood products that contain antibodies, such as in immunoglobulin therapy or antiserum therapy. Passive immunization is used when there is a high risk of infection and insufficient time for the body to develop its own immune response, or to reduce the symptoms of ongoing or immunosuppressive diseases. Passive immunization can be provided when people cannot synthesize antibodies, and when they have been exposed to a disease that they do not have immunity against.

Infant nutrition is the description of the dietary needs of infants. A diet lacking essential calories, minerals, vitamins, or fluids is considered inadequate. Breast milk provides the best nutrition for these vital first months of growth when compared to infant formula. For example, breastfeeding aids in preventing anemia, obesity, and sudden infant death syndrome; and it promotes digestive health, immunity, intelligence, and dental development. The American Academy of Pediatrics recommends exclusively feeding an infant breast milk, or iron fortified formula, for the first six months of life and continuing for one year or longer as desired by infant and mother. Infants are usually not introduced to solid foods until four to six months of age. Historically, breastfeeding infants was the only option for nutrition otherwise the infant would perish. Breastfeeding is rarely contraindicated, but is not recommended for mothers being treated for cancer, those with active tuberculosis, HIV, substance abuse, or leukemia. Clinicians can be consulted to determine what the best source of infant nutrition is for each baby.

Serum-derived bovine immunoglobulin/protein isolate (SBI) is a medical food product derived from bovine serum obtained from adult cows in the United States. It is sold under the name EnteraGam.

Neonatal infection Human disease

Neonatal infections are infections of the neonate (newborn) acquired during prenatal development or in the first four weeks of life. Neonatal infections may be contracted by mother to child transmission, in the birth canal during childbirth, or contracted after birth. Some neonatal infections are apparent soon after delivery, while others may develop in the postnatal period. Some neonatal infections such as HIV, hepatitis B, and malaria do not become apparent until much later.

Milk fat globule membrane

Milk fat globule membrane (MFGM) is a complex and unique structure composed primarily of lipids and proteins that surrounds milk fat globule secreted from the milk producing cells of humans and other mammals. It is a source of multiple bioactive compounds, including phospholipids, glycolipids, glycoproteins, and carbohydrates that have important functional roles within the brain and gut.

Human milk microbiome Community of microorganisms in human milk

The human milk microbiota, also known as human milk probiotics (HMP), refers to the microbiota residing in the human mammary glands and breast milk. Human breast milk has been traditionally assumed to be sterile, but more recently both microbial culture and culture-independent techniques have confirmed that human milk contains diverse communities of bacteria which are distinct from other microbial communities inhabiting the human body.

Human milk immunity

Human milk immunity refers to the protection provided by mother to infant via the biologically active components in human milk. Human milk was previously thought to only provide passive immunity primarily through Secretory IgA, but advances in technology have led to the identification of various immune-modulating components. Human milk constituents provide nutrition and protect the immunologically naive infant as well as regulate the infant's own immune development and growth.

References

  1. Gottstein, Michael. Colostrum is vital ingredient to keep newborn lambs alive. Irish Independent. 3 March 2009.
  2. Peter Bird, Northamptonshire ACRE 'Village Voices' oral history recordings, Northamptonshire ACRE and Northamptonshire County Archives
  3. Ballard, Olivia; Morrow, Ardythe L. (February 2013). "Human Milk Composition: Nutrients and Bioactive Factors". Pediatric Clinics of North America. 60 (1): 49–74. doi:10.1016/j.pcl.2012.10.002. ISSN   0031-3955. PMC   3586783 . PMID   23178060.
  4. Sangild, P. T.; Thymann, T.; Schmidt, M.; Stoll, B.; Burrin, D. G.; Buddington, R. K. (2013-10-01). "Invited Review: The preterm pig as a model in pediatric gastroenterology". Journal of Animal Science. 91 (10): 4713–4729. doi:10.2527/jas.2013-6359. ISSN   0021-8812. PMC   3984402 . PMID   23942716.
  5. Newburg, David S.; Walker, W. Allan (January 2007). "Protection of the neonate by the innate immune system of developing gut and of human milk". Pediatric Research. 61 (1): 2–8. doi: 10.1203/01.pdr.0000250274.68571.18 . ISSN   0031-3998. PMID   17211132. S2CID   22878097.
  6. Stelwagen, K.; Carpenter, E.; Haigh, B.; Hodgkinson, A.; Wheeler, T. T. (April 2009). "Immune components of bovine colostrum and milk". Journal of Animal Science. 87 (13 Suppl): 3–9. doi:10.2527/jas.2008-1377. ISSN   1525-3163. PMID   18952725.
  7. Rathe, Mathias; Müller, Klaus; Sangild, Per Torp; Husby, Steffen (April 2014). "Clinical applications of bovine colostrum therapy: a systematic review". Nutrition Reviews. 72 (4): 237–254. doi:10.1111/nure.12089. ISSN   1753-4887. PMID   24571383.
  8. "It's Only Natural". 2017-06-09.
  9. Bertotto, A; Castellucci, G; Fabietti, G; Scalise, F; Vaccaro, R (1 November 1990). "Lymphocytes bearing the T cell receptor gamma delta in human breast milk". Arch Dis Child. 65 (11): 1274–5. doi:10.1136/adc.65.11.1274-a. PMC   1792611 . PMID   2147370.
  10. Groves, ML (1960). "The isolation of a red protein from milk". Journal of the American Chemical Society. 82 (13): 3345–3360. doi:10.1021/ja01498a029.
  11. Paulík S, Slanina L, Polácek M (January 1985). "[Lysozyme in the colostrum and blood of calves and dairy cows]". Vet Med (Praha) (in Slovak). 30 (1): 21–8. PMID   3918380.
  12. Reiter B (1978). "The lactoperoxidase-thiocyanate-hydrogen peroxide antibacterium system". Ciba Found. Symp. Novartis Foundation Symposia (65): 285–94. doi:10.1002/9780470715413.ch16. ISBN   9780470715413. PMID   225143.
  13. Brock, JH; et al. (1975). "Bactericidal and hemolytic activity of complement in bovine colostrum and serum: effect of proteolytic enzymes and ethylene glycol tetraacetic acid (EGTA)". Annales d'Immunologie. 126C (4): 439–451.
  14. Zabłocka A, Janusz M, Rybka K, Wirkus-Romanowska I, Kupryszewski G, Lisowski J (2001). "Cytokine-inducing activity of a proline-rich polypeptide complex (PRP) from ovine colostrum and its active nonapeptide fragment analogs". Eur. Cytokine Netw. 12 (3): 462–7. PMID   11566627.
  15. 1 2 Hagiwara K, Kataoka S, Yamanaka H, Kirisawa R, Iwai H (October 2000). "Detection of cytokines in bovine colostrum". Vet. Immunol. Immunopathol. 76 (3–4): 183–90. doi:10.1016/S0165-2427(00)00213-0. PMID   11044552.
  16. Rudloff HE, Schmalstieg FC, Mushtaha AA, Palkowetz KH, Liu SK, Goldman AS (January 1992). "Tumor necrosis factor-alpha in human milk". Pediatr. Res. 31 (1): 29–33. doi: 10.1203/00006450-199201000-00005 . PMID   1375729.
  17. Maheshwari A, Christensen RD, Calhoun DA (November 2003). "ELR+ CXC chemokines in human milk". Cytokine. 24 (3): 91–102. doi:10.1016/j.cyto.2003.07.002. PMID   14581003.
  18. Xu RJ (1996). "Development of the newborn GI tract and its relation to colostrum/milk intake: a review". Reprod. Fertil. Dev. 8 (1): 35–48. doi:10.1071/RD9960035. PMID   8713721.
  19. O'Dell SD, Day IN (July 1998). "Insulin-like growth factor II (IGF-II)". Int. J. Biochem. Cell Biol. 30 (7): 767–71. doi:10.1016/S1357-2725(98)00048-X. PMID   9722981.
  20. Okada M, Ohmura E, Kamiya Y, et al. (1991). "Transforming growth factor (TGF)-alpha in human milk". Life Sci. 48 (12): 1151–6. doi:10.1016/0024-3205(91)90452-H. PMID   2002746.
  21. Saito S, Yoshida M, Ichijo M, Ishizaka S, Tsujii T (October 1993). "Transforming growth factor-beta (TGF-beta) in human milk". Clin. Exp. Immunol. 94 (1): 220–4. doi:10.1111/j.1365-2249.1993.tb06004.x. PMC   1534356 . PMID   8403511.
  22. Tokuyama Y, Tokuyama H (February 1993). "Purification and identification of TGF-beta 2-related growth factor from bovine colostrum". J. Dairy Res. 60 (1): 99–109. doi:10.1017/S0022029900027382. PMID   8436667.
  23. Hironaka, T; et al. (1997). "Identification and partial purification of a basic fibroblast growth factor-like growth factor derived from bovine colostrum". Journal of Dairy Science. 80 (3): 488–495. doi: 10.3168/jds.s0022-0302(97)75961-7 . PMID   9098798.
  24. Xiao X, Xiong A, Chen X, Mao X, Zhou X (March 2002). "Epidermal growth factor concentrations in human milk, cow's milk and cow's milk-based infant formulas". Chin. Med. J. 115 (3): 451–4. PMID   11940387.
  25. 1 2 Playford RJ, Macdonald CE, Johnson WS (July 2000). "Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders". Am. J. Clin. Nutr. 72 (1): 5–14. doi: 10.1093/ajcn/72.1.5 . PMID   10871554.
  26. Vuorela P, Andersson S, Carpén O, Ylikorkala O, Halmesmäki E (November 2000). "Unbound vascular endothelial growth factor and its receptors in breast, human milk, and newborn intestine". Am. J. Clin. Nutr. 72 (5): 1196–201. doi: 10.1093/ajcn/72.5.1196 . PMID   11063449.
  27. Flidel-Rimon O, Roth P (November 1997). "Effects of milk-borne colony stimulating factor-1 on circulating growth factor levels in the newborn infant". J. Pediatr. 131 (5): 748–50. doi:10.1016/S0022-3476(97)70105-7. PMID   9403658.
  28. McGrath, Brian A.; Fox, Patrick F.; McSweeney, Paul L. H.; Kelly, Alan L. (2016-03-01). "Composition and properties of bovine colostrum: a review". Dairy Science & Technology. 96 (2): 133–158. doi: 10.1007/s13594-015-0258-x . ISSN   1958-5594. S2CID   83925224.
  29. Ulfman, Laurien H.; Leusen, Jeanette H. W.; Savelkoul, Huub F. J.; Warner, John O.; van Neerven, R. J. Joost (2018-06-22). "Effects of Bovine Immunoglobulins on Immune Function, Allergy, and Infection". Frontiers in Nutrition. 5: 52. doi:10.3389/fnut.2018.00052. ISSN   2296-861X. PMC   6024018 . PMID   29988421.
  30. Cesarone, Maria Rosaria; Belcaro, Gianni; Di Renzo, Andrea; Dugall, Mark; Cacchio, Marisa; Ruffini, Irma; Pellegrini, Luciano; Del Boccio, Gilberto; Fano, Filiberto; Ledda, Andrea; Bottari, Angelica (April 2007). "Prevention of Influenza Episodes With Colostrum Compared With Vaccination in Healthy and High-Risk Cardiovascular Subjects: The Epidemiologic Study in San Valentino". Clinical and Applied Thrombosis/Hemostasis. 13 (2): 130–136. doi: 10.1177/1076029606295957 . ISSN   1076-0296. PMID   17456621. S2CID   22882696.
  31. 1 2 Saad, Khaled; Abo-Elela, Mohamed Gamil M.; El-Baseer, Khaled A. Abd; Ahmed, Ahmed E.; Ahmad, Faisal-Alkhateeb; Tawfeek, Mostafa S. K.; El-Houfey, Amira A.; Aboul_Khair, Mohamed Diab; Abdel-Salam, Ahmad M.; Abo-elgheit, Amir; Qubaisy, Heba (2016-09-16). "Effects of bovine colostrum on recurrent respiratory tract infections and diarrhea in children". Medicine. 95 (37): e4560. doi:10.1097/MD.0000000000004560. ISSN   0025-7974. PMC   5402550 . PMID   27631207.
  32. Filipescu, Iulia Elena; Leonardi, Leonardo; Menchetti, Laura; Guelfi, Gabriella; Traina, Giovanna; Casagrande-Proietti, Patrizia; Piro, Federica; Quattrone, Alda; Barbato, Olimpia; Brecchia, Gabriele (2018-08-23). "Preventive effects of bovine colostrum supplementation in TNBS-induced colitis in mice". PLOS ONE. 13 (8): e0202929. doi:10.1371/journal.pone.0202929. ISSN   1932-6203. PMC   6107273 . PMID   30138385.
  33. "Dairy in Human Health and Disease Across the Lifespan | ScienceDirect". www.sciencedirect.com. Retrieved 2020-09-30.
  34. Playford, R. J. (2001-06-01). "Peptide therapy and the gastroenterologist: colostrum and milk-derived growth factors". Clinical Nutrition. Proceedings of the 11th Nutricia Symposium Recent Developments in Clinical Nutrition. 20: 101–106. doi:10.1054/clnu.2001.0434. ISSN   0261-5614.
  35. 1 2 Barakat, Sana Hosny; Meheissen, Marwa Ahmed; Omar, Omneya Magdy; Elbana, Doaa Ali (2020-02-01). "Bovine Colostrum in the Treatment of Acute Diarrhea in Children: A Double-Blinded Randomized Controlled Trial". Journal of Tropical Pediatrics. 66 (1): 46–55. doi:10.1093/tropej/fmz029. PMID   31168590.
  36. 1 2 Patel, Kamlesh; Rana, Rajiv (July 2006). "Pedimune in recurrent respiratory infection and diarrhoea--the Indian experience--the pride study". Indian Journal of Pediatrics. 73 (7): 585–591. doi:10.1007/BF02759923. ISSN   0973-7693. PMID   16877852. S2CID   26464312.
  37. Pakkanen, R.; Aalto, J. (1997-05-01). "Growth factors and antimicrobial factors of bovine colostrum". International Dairy Journal. 7 (5): 285–297. doi:10.1016/S0958-6946(97)00022-8. ISSN   0958-6946.
  38. 1 2 Gopal, Pramod K.; Gill, H. S. (November 2000). "Oligosaccharides and glycoconjugates in bovine milk and colostrum". British Journal of Nutrition. 84 (S1): 69–74. doi: 10.1017/S0007114500002270 . ISSN   1475-2662. PMID   11242449.
  39. Mehra R, Sing R, Kumar N, et al. UGC Sponsored National Conference on Food Safety, Nutritional Security and Sustainability. 2020. ISBN 978-81-942875-0-
  40. Huppertz HI, Rutkowski S, Busch DH, Eisebit R, Lissner R, Karch H. Journal of pediatric gastroenterology and nutrition. 1999;29(4):452-6.
  41. Buckley, J. D.; Abbott, M. J.; Brinkworth, G. D.; Whyte, P. B. D. (June 2002). "Bovine colostrum supplementation during endurance running training improves recovery, but not performance". Journal of Science and Medicine in Sport. 5 (2): 65–79. doi:10.1016/s1440-2440(02)80028-7. ISSN   1440-2440. PMID   12188088.
  42. Brinkworth, Grant D.; Buckley, Jonathan D.; Slavotinek, John P.; Kurmis, Andrew P. (January 2004). "Effect of bovine colostrum supplementation on the composition of resistance trained and untrained limbs in healthy young men". European Journal of Applied Physiology. 91 (1): 53–60. doi:10.1007/s00421-003-0944-x. ISSN   1439-6319. PMID   14504943. S2CID   35803322.
  43. Duff, Whitney R. D.; Chilibeck, Philip D.; Rooke, Julianne J.; Kaviani, Mojtaba; Krentz, Joel R.; Haines, Deborah M. (June 2014). "The effect of bovine colostrum supplementation in older adults during resistance training". International Journal of Sport Nutrition and Exercise Metabolism. 24 (3): 276–285. doi:10.1123/ijsnem.2013-0182. ISSN   1543-2742. PMID   24281841.
  44. Kotsis, Yiannis; Mikellidi, Anastasia; Aresti, Cleopatra; Persia, Eleni; Sotiropoulos, Aristomenis; Panagiotakos, Demosthenes B.; Antonopoulou, Smaragdi; Nomikos, Tzortzis (April 2018). "A low-dose, 6-week bovine colostrum supplementation maintains performance and attenuates inflammatory indices following a Loughborough Intermittent Shuttle Test in soccer players". European Journal of Nutrition. 57 (3): 1181–1195. doi:10.1007/s00394-017-1401-7. ISSN   1436-6215. PMC   5861165 . PMID   28285432.
  45. Balfour, W. E.; Comline, R. S. (1962). "Acceleration of the absorption of unchanged globulins in the new-born calf by factors in colostrum". J. Physiol. 160 (2): 234–257. doi:10.1113/jphysiol.1962.sp006844. PMC   1359530 . PMID   16992118.
  46. Bush, L. J.; Staley, T. E. (1980). "Absorption of colostral immunoglobulins in newborn calves". J. Dairy Sci. 63 (4): 672–680. doi: 10.3168/jds.s0022-0302(80)82989-4 . PMID   6991559.
  47. Staley, T. E.; Bush, L. J. (1985). "Receptor mechanisms of the neonatal intestine and their relationship to immunoglobulin absorption and disease". J. Dairy Sci. 68 (1): 184–205. doi: 10.3168/jds.s0022-0302(85)80812-2 . PMID   3884680.
  48. Jensen, A. R.; Elnif, J.; Burrin, D. G.; Sangild, P. T. (2001). "Development of intestinal immunoglobulins absorption and enzyme activities in neonatal pigs is diet dependent". J. Nutr. 131 (12): 3259–3265. doi: 10.1093/jn/131.12.3259 . PMID   11739877.
  49. Sawyer, M.; Willadsen, C. H.; Osburn, B. I.; McGuire, T. C. (1977). "Passive transfer of colostral immunoglobulins from ewe to lamb and its influence on neonatal lamb mortality". J. Am. Vet. Med. Assoc. 171 (12): 1255–1259. PMID   604324.
  50. Pakkanen R, Aalto J.; Aalto (1997). "Growth Factors and Antimicrobial Factors of Bovine Colostrum". International Dairy Journal. 7 (5): 285–297. doi:10.1016/S0958-6946(97)00022-8.
  51. 1 2 McConnell, M. A.; Buchan, G.; Borissenko, M. V.; Brooks, H. J. L. (2001). "A comparison of IgG and IgG1 activity in an early milk concentrate from non-immunised cows and a milk from hyperimmunised animals". Food Research International. 34 (2–3): 255–261. doi:10.1016/S0963-9969(00)00163-0.
  52. SABIN, AB. (November 1950). "Antipoliomyelitic substance in milk of human beings and certain cows". AMA Am J Dis Child. 80 (5): 866–7. PMID   14777169.
  53. Pallasch, TJ. (October 2003). "Antibiotic prophylaxis: problems in paradise". Dent Clin North Am. 47 (4): 665–79. doi:10.1016/S0011-8532(03)00037-5. PMID   14664458.
  54. Buttar, H. S., Bagwe, S. M., Bhullar, S. K., & Kaur, G. (2017). Health benefits of bovine colostrum in children and adults. In R. R. Watson, R. J. Collier & V. R. Preedy (Eds.), Dairy in human health and disease across the lifespan (pp. 3-20). London: Academic Press.
  55. Playford, R. J.; Woodman, A. C.; Clark, P.; Watanapa, P.; Vesey, D.; Deprez, P. H.; Williamson, R. C.; Calam, J. (1993-04-03). "Effect of luminal growth factor preservation on intestinal growth". Lancet. 341 (8849): 843–848. doi:10.1016/0140-6736(93)93057-8. ISSN   0140-6736. PMID   8096559. S2CID   30904879.
  56. Davison, Glen; Marchbank, Tania; March, Daniel S.; Thatcher, Rhys; Playford, Raymond J. (1 August 2016). "Zinc carnosine works with bovine colostrum in truncating heavy exercise-induced increase in gut permeability in healthy volunteers". The American Journal of Clinical Nutrition. 104 (2): 526–536. doi: 10.3945/ajcn.116.134403 . ISSN   1938-3207. PMID   27357095.
  57. Marchbank, Tania; Davison, Glen; Oakes, Jemma R.; Ghatei, Mohammad A.; Patterson, Michael; Moyer, Mary Pat; Playford, Raymond J. (1 March 2011). "The nutriceutical bovine colostrum truncates the increase in gut permeability caused by heavy exercise in athletes". American Journal of Physiology. Gastrointestinal and Liver Physiology. 300 (3): G477–484. doi:10.1152/ajpgi.00281.2010. ISSN   1522-1547. PMID   21148400. S2CID   1829471.
  58. Playford, R. J.; MacDonald, C. E.; Calnan, D. P.; Floyd, D. N.; Podas, T.; Johnson, W.; Wicks, A. C.; Bashir, O.; Marchbank, T. (1 June 2001). "Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability". Clinical Science. 100 (6): 627–633. doi:10.1042/cs1000627. ISSN   0143-5221. PMID   11352778. S2CID   24586050.
  59. Khan, Z.; Macdonald, C.; Wicks, A. C.; Holt, M. P.; Floyd, D.; Ghosh, S.; Wright, N. A.; Playford, R. J. (1 November 2002). "Use of the 'nutriceutical', bovine colostrum, for the treatment of distal colitis: results from an initial study". Alimentary Pharmacology & Therapeutics. 16 (11): 1917–1922. doi:10.1046/j.1365-2036.2002.01354.x. ISSN   0269-2813. PMID   12390100. S2CID   30564496.
  60. Uruakpa, F; Ismond, M.A.H; Akobundu, E.N.T (2002). "Colostrum and its benefits: a review". Nutrition Research. 22 (6): 755–767. doi:10.1016/S0271-5317(02)00373-1.
  61. Playford, RJ.; Floyd, DN.; Macdonald, CE.; Calnan, DP.; Adenekan, RO.; Johnson, W.; Goodlad, RA.; Marchbank, T. (May 1999). "Bovine colostrum is a health food supplement which prevents NSAID induced gut damage". Gut. 44 (5): 653–8. doi:10.1136/gut.44.5.653. PMC   1727496 . PMID   10205201.
  62. Carver, JD.; Barness, LA. (June 1996). "Trophic factors for the gastrointestinal tract". Clin Perinatol. 23 (2): 265–85. doi:10.1016/S0095-5108(18)30242-2. PMID   8780905.
  63. Baumgart, Daniel C.; Dignass, Axel U. (1 November 2002). "Intestinal barrier function". Current Opinion in Clinical Nutrition and Metabolic Care. 5 (6): 685–694. doi:10.1097/00075197-200211000-00012. ISSN   1363-1950. PMID   12394645. S2CID   2326543.
  64. Playford, R. J.; Macdonald, C. E.; Johnson, W. S. (1 July 2000). "Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders". The American Journal of Clinical Nutrition. 72 (1): 5–14. doi: 10.1093/ajcn/72.1.5 . ISSN   0002-9165. PMID   10871554.
  65. Kelly, Gregory S. (1 November 2003). "Bovine colostrums: a review of clinical uses". Alternative Medicine Review: A Journal of Clinical Therapeutic. 8 (4): 378–394. ISSN   1089-5159. PMID   14653766.
  66. 1 2 Hofman, Z.; Smeets, R.; Verlaan, G.; Lugt, R.; Verstappen, PA. (December 2002). "The effect of bovine colostrum supplementation on exercise performance in elite field hockey players". Int J Sport Nutr Exerc Metab. 12 (4): 461–9. doi:10.1123/ijsnem.12.4.461. PMID   12500989. S2CID   28204567.
  67. Buckley, JD.; Abbott, MJ.; Brinkworth, GD.; Whyte, PB. (June 2002). "Bovine colostrum supplementation during endurance running training improves recovery, but not performance". J Sci Med Sport. 5 (2): 65–79. doi:10.1016/S1440-2440(02)80028-7. PMID   12188088.
  68. Ray Playford et al. (2011). The nutriceutical, bovine colostrum, truncates the increase in gut permeability caused by heavy exercise in athletes. American Journal of Physiology. Gastrointestinal and Liver Physiology, (March 2011).
  69. Berk, LS.; Nieman, DC.; Youngberg, WS.; Arabatzis, K.; Simpson-Westerberg, M.; Lee, JW.; Tan, SA.; Eby, WC. (April 1990). "The effect of long endurance running on natural killer cells in marathoners". Med Sci Sports Exerc. 22 (2): 207–12. PMID   2355818.
  70. Antonio, J.; Sanders, MS.; Van Gammeren, D. (March 2001). "The effects of bovine colostrum supplementation on body composition and exercise performance in active men and women". Nutrition. 17 (3): 243–7. doi:10.1016/S0899-9007(00)00552-9. PMID   11312068.
  71. Arai, Y.; Hirose, N.; Yamamura, K.; Shimizu, K.; Takayama, M.; Ebihara, Y.; Osono, Y. (February 2001). "Serum insulin-like growth factor-1 in centenarians: implications of IGF-1 as a rapid turnover protein". J Gerontol A Biol Sci Med Sci. 56 (2): M79–82. doi: 10.1093/gerona/56.2.M79 . PMID   11213280.
  72. Caregaro, L.; Favaro, A.; Santonastaso, P.; Alberino, F.; Di Pascoli, L.; Nardi, M.; Favaro, S.; Gatta, A. (June 2001). "Insulin-like growth factor 1 (IGF-1), a nutritional marker in patients with eating disorders". Clin Nutr. 20 (3): 251–7. doi:10.1054/clnu.2001.0397. PMID   11407872.
  73. Rasmussen, MH.; Frystyk, J.; Andersen, T.; Breum, L.; Christiansen, JS.; Hilsted, J. (March 1994). "The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone". Metabolism. 43 (3): 315–9. doi:10.1016/0026-0495(94)90099-X. PMID   7511202.
  74. Mero, A.; Kähkönen, J.; Nykänen, T.; et al. (August 2002). "IGF-I, IgA, and IgG responses to bovine colostrum supplementation during training". J Appl Physiol. 93 (2): 732–9. doi:10.1152/japplphysiol.00002.2002. PMID   12133885.
  75. Duff, Whitney R. D.; Chilibeck, Philip D.; Rooke, Julianne J.; Kaviani, Mojtaba; Krentz, Joel R.; Haines, Deborah M. (June 2014). "The effect of bovine colostrum supplementation in older adults during resistance training". International Journal of Sport Nutrition and Exercise Metabolism. 24 (3): 276–285. doi:10.1123/ijsnem.2013-0182. ISSN   1543-2742. PMID   24281841.
  76. Wakabayashi, H.; Matsumoto, H.; Hashimoto, K.; Teraguchi, S.; Takase, M.; Hayasawa, H. (May 1999). "Inhibition of iron/ascorbate-induced lipid peroxidation by an N-terminal peptide of bovine lactoferrin and its acylated derivatives" (PDF). Biosci Biotechnol Biochem. 63 (5): 955–7. doi: 10.1271/bbb.63.955 . PMID   10380640.[ permanent dead link ]
  77. Gutteridge, JM.; Smith, A. (December 1988). "Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation". Biochem J. 256 (3): 861–5. doi:10.1042/bj2560861. PMC   1135495 . PMID   3223958.
  78. "Cooking and Food" (PDF). Manx Farming and Country Life. 9. 1991. Archived from the original (PDF) on 2010-02-15. Retrieved 2017-08-03.
  79. Otto, W; Najnigier, B; Stelmasiak, T; Robins-Browne, RM (2011). "Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by enterotoxigenic Escherichia coli in volunteers". Scand J Gastroenterol. 46 (7–8): 862–8. doi:10.3109/00365521.2011.574726. PMC   3154584 . PMID   21526980.
  80. TGA guidance BCP
  81. Lawrence HS (August 1949). "The cellular transfer of cutaneous hypersensitivity to tuberculin in man". Proc. Soc. Exp. Biol. Med. 71 (4): 516–22. doi:10.3181/00379727-71-17242. PMID   18139800. S2CID   37728884.
  82. Janusz M, Lisowski J, Franĕk F (December 1974). "Isolation and characterization of a proline-rich polypeptide from ovine colostrum". FEBS Lett. 49 (2): 276–9. doi: 10.1016/0014-5793(74)80529-6 . PMID   4442608. S2CID   2495375.
  83. Zimecki M (2008). "A proline-rich polypeptide from ovine colostrum: colostrinin with immunomodulatory activity". Bioactive Components of Milk. Adv. Exp. Med. Biol. Advances in Experimental Medicine and Biology. 606. pp. 241–50. doi:10.1007/978-0-387-74087-4_9. ISBN   978-0-387-74086-7. PMID   18183932.
  84. Levin AS; Spitler; Fudenberg (1975). "Transfer factor I: methods of therapy". Birth Defects Orig. Artic. Ser. 11 (1): 445–8. PMID   1080060.